comparemela.com

Latest Breaking News On - Oncology research development susan galbraith - Page 1 : comparemela.com

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering. The Cambridge,.

China
Cambridge
Cambridgeshire
United-kingdom
Japan
Tokyo
Rd-ken-takeshita
Daiichi-sankyo
Greg-rosenvinge
Committee-for-medicinal-products-human
Daiichi-sankyo-co-ltd
Oncology-research-development-susan-galbraith

AstraZenca's Enhertu improves breast cancer survival outcomes

AstraZenca s Enhertu improves breast cancer survival outcomes | Financial News

Cambridge
Cambridgeshire
United-kingdom
Daiichi-sankyo-co-ltd
Astrazeneca
Oncology-research-development-susan-galbraith
Alliance-news
Vice-president
Oncology-research
Development-susan-galbraith
Elizabeth-winter

vimarsana © 2020. All Rights Reserved.